• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    More On RANBAXY.BO

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Ranbaxy Laboratories Ltd. (RANBAXY.BO)

    -BSE
    703.65 Down 4.35(0.61%) Jan 30, 5:11AM EST
    Add to Portfolio
    Prev Close:708.00
    Open:708.00
    Bid:703.65
    Ask:706.00
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:695.75 - 714.00
    52wk Range:308.00 - 724.95
    Volume:87,503
    Avg Vol (3m):113,188
    Market Cap:298.67B
    P/E (ttm):502.97
    EPS (ttm):1.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in INR.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.73
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ranbaxy Laboratories Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical products. The company offers generics, differentiated products, over-the-counter products, anti-retrovirals, active pharmaceutical ingredien... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback